GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dr Reddy's Laboratories Ltd (BSP:R1DY34) » Definitions » Cyclically Adjusted FCF per Share

Dr Reddy's Laboratories (BSP:R1DY34) Cyclically Adjusted FCF per Share : R$1.08 (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Dr Reddy's Laboratories Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Dr Reddy's Laboratories's adjusted free cash flow per share for the three months ended in Dec. 2023 was R$-0.018. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is R$1.08 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Dr Reddy's Laboratories's average Cyclically Adjusted FCF Growth Rate was 19.90% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 20.70% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 21.30% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 15.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Dr Reddy's Laboratories was 31.10% per year. The lowest was 1.20% per year. And the median was 16.75% per year.

As of today (2024-04-28), Dr Reddy's Laboratories's current stock price is R$62.64. Dr Reddy's Laboratories's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was R$1.08. Dr Reddy's Laboratories's Cyclically Adjusted Price-to-FCF of today is 58.00.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Dr Reddy's Laboratories was 117.05. The lowest was 41.17. And the median was 61.60.


Dr Reddy's Laboratories Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Dr Reddy's Laboratories's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Reddy's Laboratories Cyclically Adjusted FCF per Share Chart

Dr Reddy's Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 1.06 1.00 1.05

Dr Reddy's Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.05 1.05 0.94 1.18 1.08

Competitive Comparison of Dr Reddy's Laboratories's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Dr Reddy's Laboratories's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dr Reddy's Laboratories's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dr Reddy's Laboratories's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Dr Reddy's Laboratories's Cyclically Adjusted Price-to-FCF falls into.



Dr Reddy's Laboratories Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Dr Reddy's Laboratories's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.018/153.2548*153.2548
=-0.018

Current CPI (Dec. 2023) = 153.2548.

Dr Reddy's Laboratories Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 0.224 91.425 0.375
201406 0.085 94.103 0.138
201409 0.079 96.780 0.125
201412 -0.092 96.780 -0.146
201503 0.368 97.163 0.580
201506 0.276 99.841 0.424
201509 0.443 101.753 0.667
201512 0.407 102.901 0.606
201603 0.307 102.518 0.459
201606 -0.137 105.961 -0.198
201609 -1.176 105.961 -1.701
201612 0.106 105.196 0.154
201703 0.247 105.196 0.360
201706 -0.243 107.109 -0.348
201709 0.166 109.021 0.233
201712 0.215 109.404 0.301
201803 0.209 109.786 0.292
201806 -0.420 111.317 -0.578
201809 0.501 115.142 0.667
201812 0.801 115.142 1.066
201903 0.250 118.202 0.324
201906 0.468 120.880 0.593
201909 0.517 123.175 0.643
201912 0.347 126.235 0.421
202003 0.030 124.705 0.037
202006 0.620 127.000 0.748
202009 0.484 130.118 0.570
202012 -0.037 130.889 -0.043
202103 0.625 131.771 0.727
202106 -0.465 134.084 -0.531
202109 -0.151 135.847 -0.170
202112 0.966 138.161 1.072
202203 0.333 138.822 0.368
202206 -0.132 142.347 -0.142
202209 0.390 144.661 0.413
202212 1.284 145.763 1.350
202303 1.010 146.865 1.054
202306 -0.054 150.280 -0.055
202309 0.831 151.492 0.841
202312 -0.018 153.255 -0.018

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Dr Reddy's Laboratories  (BSP:R1DY34) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Dr Reddy's Laboratories's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=62.64/1.08
=58.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Dr Reddy's Laboratories was 117.05. The lowest was 41.17. And the median was 61.60.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Dr Reddy's Laboratories Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Dr Reddy's Laboratories's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Dr Reddy's Laboratories (BSP:R1DY34) Business Description

Address
8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, IND, 500 034
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (22% of its generics sales), Russia (12%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Dr Reddy's Laboratories (BSP:R1DY34) Headlines

No Headlines